These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 602937)

  • 1. Absence of VIII AHF response to adrenalin in hemophilia A.
    Eyster ME; Dranchak M; Haverstick J; Rogers JS
    Am J Hematol; 1977; 3():193-8. PubMed ID: 602937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
    J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of factor VIII-like antigen (VIII AGN) and clot promoting acitivty (VIII AHF) as measured by one- and two-stage assays in patients with liver disease.
    Rogers JS; Eyster E
    Br J Haematol; 1976 Dec; 34(4):655-61. PubMed ID: 990195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier detection in classic hemophilia by combined measurement of immunologic (VIII AGN) and procoagulant (VIII AHF) activities.
    Eyster ME; Jones MB; Moore T; Delli-Bovi L
    Am J Clin Pathol; 1976 Jun; 65(6):975-81. PubMed ID: 937252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease.
    Weiss HJ; Sussman II; Hoyer LW
    J Clin Invest; 1977 Aug; 60(2):390-404. PubMed ID: 17621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered serum factor VIII-related antigen (VIII : AGN)/von Willebrand factor (VIII : vWf) in haemophiliacs with inhibitors to factor VIII procoagulant activity (VIII : C).
    Ballard JO; Sanders JC; Eyster ME
    Thromb Haemost; 1981 Feb; 45(1):68-72. PubMed ID: 6166064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carriers with excessively low factor VIII procoagulant activity (VIII AHF): a study of two unrelated families with mild hemophilia A.
    Eyster ME; Ladda RL; Bowman HS
    Blood; 1977 Apr; 49(4):607-18. PubMed ID: 843619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
    Weiss HJ; Rogers J; Brand H
    J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient deficiency of antihemophilic factor (AHF) procoagulant and AHF-like antigen during administration of tetracycline.
    Stefanini M
    Am J Clin Pathol; 1980 Mar; 73(3):439-43. PubMed ID: 7361727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procoagulant specificity of factor VIII inhibitor.
    Yang HC; Kuzur M
    Br J Haematol; 1977 Nov; 37(3):429-33. PubMed ID: 304738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques.
    Bennett B; Ratnoff OD
    J Clin Invest; 1972 Oct; 51(10):2593-6. PubMed ID: 4626847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The laboratory diagnosis of the carrier state for classic hemophilia.
    Ratnoff OD; Jones PK
    Ann Intern Med; 1977 May; 86(5):521-8. PubMed ID: 851299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoradiometric assay of procoagulant factor VIII antigen (VIIICAG).
    Muller HP; van Tilburg NH; Bertina RM; Terwiel JP; Veltkamp JJ
    Clin Chim Acta; 1980 Oct; 107(1-2):11-9. PubMed ID: 6775848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sources of variability in antihemophilic factor (factor VIII) procoagulant titers and precipitating antigen levels among obligate carriers of classic hemophilia.
    Jones PK; Ratnoff OD
    Blood; 1981 May; 57(5):928-32. PubMed ID: 6783148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating anticoagulant in a family with prolonged bleeding time and factor VIII deficiency.
    Diez-Ewald M; Lian EC; Nunez R; Deykin D; Harkness DR
    Blood; 1977 May; 49(5):799-806. PubMed ID: 851643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoradiometric measurement of the factor VIII procoagulant antigen.
    Lazarchick J; Hoyer LW
    J Clin Invest; 1978 Nov; 62(5):1048-52. PubMed ID: 81838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultracentrifugal analysis of factor VIII and von Willebrand factor in therapeutic preparations.
    Aronson DL; Chang P
    Vox Sang; 1995; 69(1):8-13. PubMed ID: 7483501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the nature of antihemophilic factor (factor VIII). Further evidence relating the AHF-like antigens in normal and hemophilic plasmas.
    Bennett B; Forman WB; Ratnoff OD
    J Clin Invest; 1973 Sep; 52(9):2191-7. PubMed ID: 4199413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor VIII:C and VIII:CAg response in patients with haemophilia A and von Willebrand's disease after administration of different factor VIII concentrates or plasma.
    Holmberg L; Borge L; Nilsson IM
    Br J Haematol; 1981 Apr; 47(4):587-96. PubMed ID: 6783063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihemophilic factor (factor VIII).
    Ratnoff OD
    Ann Intern Med; 1978 Mar; 88(3):403-9. PubMed ID: 343683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.